Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16 kDa protein in a model of progressive pulmonary infection

International Journal of Medical Microbiology

Volumn 299, Issue 6, 2009, Pages 447-452

  López, Yamilé ^a   Yero, Daniel ^a   Falero Diaz, Gustavo ^a   Olivares, Nesty ^a   Sarmiento, María E ^a   Sifontes, Sergio ^a   Solis, Rosa L ^a   Barrios, Jorge A ^b   Aguilar, Diana ^b   Hernández Pando, Rogelio ^b   Acosta, Armando ^a  

^a FINLAY INSTITUTE   (Cuba)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

16 kDa; 38 kDa; BCG; Monoclonal antibody; Tuberculosis

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN A; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY TBA61; MONOCLONAL ANTIBODY TBA84; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BACTERIAL STRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MALE; MORPHOMETRICS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; COLONY COUNT, MICROBIAL; FEMALE; IMMUNOGLOBULIN A; LUNG; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 68949192449     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2008.10.007     Document Type: Article

References (26)

1. Acosta A., Sarmiento M.E., Gonzalez A., Estevez P., Aguila A., Infante J.F., Izquierdo L., Capo V., Sierra G., and Malberty J.A. Histopathologic and humoral study of Balb/c mice inoculated with BCG by different routes. Arch. Med. Res. 25 (1994) 159-163
2. Andersen P., and Doherty T.M. TB subunit vaccines - putting the pieces together. Microbes Infect. 7 (2005) 911-921
3. Arriaga A.K., Orozco E.H., Aguilar L.D., Rook G.A., and Hernandez P.R. Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin. Exp. Immunol. 128 (2002) 229-237
4. Bretscher P.A., Hamilton D., and Ogunremi O. What information is needed to design effective vaccination against intracellular pathogens causing chronic disease?. Expert Rev. Vaccines 1 (2002) 179-192
5. Casadevall A., and Pirofski L.A. Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol. 24 (2003) 474-478
6. Coates A.R., Hewitt J., Allen B.W., Ivanyi J., and Mitchison D.A. Antigenic diversity of Mycobacterium tuberculosis and Mycobacterium bovis detected by means of monoclonal antibodies. Lancet 2 (1981) 167-169
7. Daffe M., and Etienne G. The capsule of Mycobacterium tuberculosis and its implications for pathogenicity. Tuber. Lung Dis. 79 (1999) 153-169
8. Devi K.R., Kumar K.S., Ramalingam B., and Alamelu R. Purification and characterization of three immunodominant proteins (38, 30, and 16 kDa) of Mycobacterium tuberculosis. Protein Expression Purif. 24 (2002) 188-195
9. Dietrich G., Viret J.F., and Hess J. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG. Int. J. Med. Microbiol. 292 (2003) 441-451
10. Falero-Diaz G., Challacombe S., Rahman D., Mistry M., Douce G., Dougan G., Acosta A., and Ivanyi J. Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery. Int. Arch. Allergy Immunol. 122 (2000) 143-150
11. Girard M.P., Fruth U., and Kieny M.P. A review of vaccine research and development: tuberculosis. Vaccine 23 (2005) 5725-5731
12. Glatman-Freedman A. Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy. FEMS Immunol. Med. Microbiol. 39 (2003) 9-16
13. Glatman-Freedman A., and Casadevall A. Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin. Microbiol. Rev. 11 (1998) 514-532
14. Igietseme J.U., Eko F.O., He Q., and Black C.M. Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens. Expert Rev. Vaccines 3 (2004) 23-34
15. Ivanyi J., and Thole J. Specificity and function of T and B cell recognition in tuberculosis. In: Bloom B. (Ed). Tuberculosis: Pathogenesis, Protection and Control (1994), ASM Press, Washington DC 437-458
16. Ivanyi J., Morris A.J., and Keen M. Studies with monoclonal antibodies to mycobacteria. In: Macario A.J.L., and Macario E.C. (Eds). Monoclonal Antibodies against Bacteria (1985), Academic Press, New York 59-90
17. Jain A., and Mondal R. Extensively drug-resistant tuberculosis: current challenges and threats. FEMS Immunol. Med. Microbiol. 53 (2008) 145-150
18. Lee B.Y., Hefta S.A., and Brennan P.J. Characterization of the major membrane protein of virulent Mycobacterium tuberculosis. Infect. Immun. 60 (1992) 2066-2074
19. Ly L.H., and McMurray D.N. Tuberculosis: vaccines in the pipeline. Expert Rev. Vaccines 7 (2008) 635-650
20. Olivares N., Leon A., Lopez Y., Puig A., Cadiz A., Falero G., Martinez M., Sarmiento M.E., Farinas M., Infante J.F., Sierra G., Solis R.L., and Acosta A. The effect of the administration of human gamma globulins in a model of BCG infection in mice. Tuberculosis (Edinburgh) 86 (2006) 268-272
21. Ravetch J.V., and Bolland S. IgG Fc receptors. Annu. Rev. Immunol. 19 (2001) 275-290
22. Reece S.T., and Kaufmann S.H. Rational design of vaccines against tuberculosis directed by basic immunology. Int. J. Med. Microbiol. 298 (2008) 143-150
23. Regnault A., Lankar D., Lacabanne V., Rodriguez A., Thery C., Rescigno M., Saito T., Verbeek S., Bonnerot C., Ricciardi-Castagnoli P., and Amigorena S. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189 (1999) 371-380
24. Reynolds H.Y. Identification and role of immunoglobulins in respiratory secretions. Eur. J. Respir. Dis. 9 Suppl. 153 (1987) 103-116
25. Snewin V.A., Gares M.P., Gaora P.O., Hasan Z., Brown I.N., and Young D.B. Assessment of immunity to mycobacterial infection with luciferase reporter constructs. Infect. Immun. 67 (1999) 4586-4593
26. Williams A., Reljic R., Naylor I., Clark S.O., Falero-Diaz G., Singh M., Challacombe S., Marsh P.D., and Ivanyi J. Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology 111 (2004) 328-333